Statins, fibrates, and venous thromboembolism: a meta-analysis.
about
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyStatins for primary prevention of venous thromboembolismStatins for primary prevention of venous thromboembolismBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesIncident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).C-reactive protein and venous thromboembolism: causal or casual association?The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study.The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis.Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysisInfluence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapyIs lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control studyAtherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study.Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis.Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort studyInhibition of renin angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic disease.Sources of tissue factor that contribute to thrombosis after rupture of an atherosclerotic plaque.Statins for the prevention of venous thromboembolism? a narrative review.A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study.Is diabetes a hypercoagulable state? A critical appraisal.Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy.Statins and venous thromboembolism: do they represent a viable therapeutic agent?Concomitant deep venous thrombosis, femoral artery thrombosis, and pulmonary embolism after air travel.Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study.Statin treatment and the risk of recurrent pulmonary embolism.Statins and venous thromboembolism: the jury is still out.Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study
P2860
Q21135505-F0815C46-6574-4DD4-805F-CF1A3557694CQ24187238-30A692D9-A8B1-45CF-AC28-A522B691EDA3Q24204040-5238A7C4-2FED-46CB-9BAA-707CD81014C9Q26853571-71AD1CC2-77CD-44BE-8A75-8330E53DF3F3Q33826794-8FDF957A-CECD-4756-AD68-B799F78D4BFFQ34130906-E849F909-4866-4AC7-99F9-CACBCFC8AF0BQ34476667-2147B165-AB7D-4067-A2CF-CA0D62171797Q35037358-7E17E883-09B7-47C4-80AF-EA4C232D6D36Q35067214-85DCF288-7269-4083-962D-3902256A9474Q35101273-2C1DFB07-0365-45B4-8987-59A6667495F2Q35624965-B4D19A6C-6512-4264-8B8B-95C8C23BEAFCQ36135460-E9A79AFD-C3FC-4AAC-BBEE-22A1855BF84EQ37176001-7B5ADDB8-4189-4CAB-BB04-6E849EF8DBC3Q37293275-46F3AAB8-5A9B-448F-9B85-243900E38F62Q37539202-B7EA3C8C-E884-42AD-A829-A74553291BC4Q37996577-5A9D67A5-EC46-40BF-91AB-1950FE78126DQ38053889-31AC9CC8-7DE2-4E56-8E70-B84B4362241EQ38113494-E70F9A4D-DB0C-4285-8366-ADB515C71C6AQ38211112-DB0004F2-0118-4AD7-8A4B-223EDE3A3272Q38409740-63943392-C3CB-4B53-89CC-2663DE9D6DD4Q38865628-1861639F-5E65-45FF-8189-748C213E1A40Q39123264-696C14CC-897D-4E3E-A7F5-7EFD03331791Q39445730-41480000-6CDB-41E3-B4EA-3D8044B764D3Q41912875-88AF10B4-C6E2-413F-8479-AA986EE5B392Q42399860-2096575D-F859-4251-A457-A5DC830EC748Q44550160-BEB8ECCD-9102-4137-AEF7-D79988A07A6BQ45746977-564DAB30-D4BD-43C1-9E60-ACB7ED967337Q56968545-2322E4F4-C3EB-404E-B057-4F45624000E9
P2860
Statins, fibrates, and venous thromboembolism: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Statins, fibrates, and venous thromboembolism: a meta-analysis.
@en
Statins, fibrates, and venous thromboembolism: a meta-analysis.
@nl
type
label
Statins, fibrates, and venous thromboembolism: a meta-analysis.
@en
Statins, fibrates, and venous thromboembolism: a meta-analysis.
@nl
prefLabel
Statins, fibrates, and venous thromboembolism: a meta-analysis.
@en
Statins, fibrates, and venous thromboembolism: a meta-analysis.
@nl
P2093
P356
P1476
Statins, fibrates, and venous thromboembolism: a meta-analysis.
@en
P2093
Achille Venco
Alessandro Squizzato
Erica Romualdi
Francesco Dentali
Luigina Guasti
Matteo Galli
Pieter W Kamphuisen
Walter Ageno
P304
P356
10.1093/EURHEARTJ/EHP556
P577
2009-12-22T00:00:00Z